According to Soleno Therapeutics's latest financial reports the company has C$0.36 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | C$0.22 B | 1035.83% |
2022-12-31 | C$19.81 M | -27.02% |
2021-12-31 | C$27.15 M | -56.74% |
2020-12-31 | C$62.76 M | 131.79% |
2019-12-31 | C$27.07 M | -17.44% |
2018-12-31 | C$32.79 M | 52.55% |
2017-12-31 | C$21.49 M | 486.87% |
2016-12-31 | C$3.66 M | -51.94% |
2015-12-31 | C$7.62 M | -17.45% |
2014-12-31 | C$9.23 M | 583.66% |
2013-12-31 | C$1.35 M | -36.98% |
2012-12-31 | C$2.14 M |